__timestamp | Bausch Health Companies Inc. | Insmed Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 246000000 | 56292000 |
Thursday, January 1, 2015 | 582800000 | 74277000 |
Friday, January 1, 2016 | 455000000 | 122721000 |
Sunday, January 1, 2017 | 366000000 | 109749000 |
Monday, January 1, 2018 | 414000000 | 145283000 |
Tuesday, January 1, 2019 | 471000000 | 131711000 |
Wednesday, January 1, 2020 | 452000000 | 181157000 |
Friday, January 1, 2021 | 465000000 | 272744000 |
Saturday, January 1, 2022 | 529000000 | 397518000 |
Sunday, January 1, 2023 | 604000000 | 571011000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Insmed Incorporated and Bausch Health Companies Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Insmed's R&D expenses surged by nearly 900%, reflecting a robust commitment to pioneering new treatments. In contrast, Bausch Health's R&D spending increased by approximately 145%, indicating a more conservative approach.
By 2023, Insmed's R&D expenditure reached a remarkable 57% of Bausch Health's, showcasing its aggressive strategy in the competitive biotech sector. This trend highlights Insmed's focus on innovation, potentially positioning it as a leader in breakthrough therapies. As the industry continues to evolve, these spending patterns offer valuable insights into each company's strategic priorities and their potential impact on future healthcare advancements.
Comparing Innovation Spending: AbbVie Inc. and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Grifols, S.A.
Research and Development Expenses Breakdown: Insmed Incorporated vs Rhythm Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Bausch Health Companies Inc.
Insmed Incorporated or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Research and Development: Comparing Key Metrics for Insmed Incorporated and Dynavax Technologies Corporation
Insmed Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Insmed Incorporated and Evotec SE
BioMarin Pharmaceutical Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Exelixis, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Bausch Health Companies Inc.